Board of Directors

The N2 Board of Directors consists of 12 individuals representing the different stakeholders within N2 membership.

Karen Arts

Karen Arts

Chair, Co-founder

Executive Director Canadian Cancer Clinical Trials Network (3CTN)

Jim Pankovich

Jim Pankovich

Vice Chair

Vice President, Clinical Operations & Drug Development-Qu Biologics Inc.

Patrick Clifford

Patrick Clifford

Treasurer

Director of Research and Innovation, CreateIT Now @ Southlake Innovation Centre – The Research Institute at Southlake

Erin Cherban

Erin Cherban

Secretary

Chief Research Officer Centre for Health Evaluation & Outcome Sciences (CHÉOS), CIHR Canadian HIV Trials Network (CTN)

 

Kathy Brodeur-Robb

Kathy Brodeur-Robb

Board Member

Executive Director C-17 Council

Scott Corley

Scott Corley

Board Member

Director of Operations-Clinical Trial Support Unit, Saskatchewan

Janette Panhuis

Janette Panhuis

Board Member

Chief Operating Officer of the Population Health Research Institute, A Joint Institute of HHS and McMaster University

Nancy Camack

Nancy Camack

Board Member

Director, Clinical Research Administration, Ottawa Hospital Research Institute (OHRI)

Rachel Syme

Rachel Syme

Board Member

Assistant Director, Institute of Cancer Research, CIHR

Tammy Mah-Fraser

Tammy Mah-Fraser

Board Member

Director, Platform Operations – Alberta Innovates – Health Solutions

Therese Gagnon-Kugler

Therese Gagnon-Kugler

Board Member

President and Chief Executive Officer, QCROC

Linda Bennett

Linda Bennett

Board Member

Project Manager, Marvelle Koffler Breast Centre Research Program